Last Price
2.84
Today's Change
+0.245 (9.44%)
Day's Change
2.66 - 2.90
Trading Volume
1,241,365
Market Cap
372 Million
Shares Outstanding
131 Million
Avg Volume
1,089,170
Avg Price (50 Days)
2.90
Avg Price (200 Days)
4.38
PE Ratio
-1.38
EPS
-2.06
Earnings Announcement
06-Mar-2025
Previous Close
2.60
Open
2.66
Day's Range
2.66 - 2.9
Year Range
2.25 - 9.77
Trading Volume
1,241,365
1 Day Change
9.44%
5 Day Change
13.60%
1 Month Change
-0.70%
3 Month Change
-15.22%
6 Month Change
-35.31%
Ytd Change
-5.02%
1 Year Change
-63.59%
3 Year Change
-81.52%
5 Year Change
-81.52%
10 Year Change
-81.52%
Max Change
-81.52%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.